Embelin Promotes Oncolytic Vaccinia Virus-Mediated Antitumor Immunity Through Disruption of IL-6/STAT3 Signaling in Lymphoma
Open Access
- 1 February 2020
- journal article
- research article
- Published by Taylor & Francis Ltd in OncoTargets and Therapy
- Vol. ume 13, 1421-1429
- https://doi.org/10.2147/ott.s209312
Abstract
Objective: Oncolytic virotherapy is a promising alternative to conventional treatment, yet limited viral replication and immune-negative feedback are the major hurdles to effective viro-immunotherapy. Methods: In this study, we found that use of an adjuvant of embelin, a small molecular inhibitor of XIAP, increased the replication of oncolytic vaccinia virus (OVV) by mitigating antiviral innate immunity. Moreover, embelin suppresses constitutive STAT3 phosphorylation and mitigates OVV-induced activation of STAT3 in lymphoma. In the subcutaneous lymphoma model, embelin significantly enhanced the therapeutic efficacy of OVV and prolonged the survival. In addition, embelin significantly increased the OVV-induced infiltration of T cells and NK cells and decreased the number of OVV-induced myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment. Results: Our results explored the ability of OVV and embelin in combination to enhance lymphoma cell lysis, revealing a beneficial combinatorial effect wherein both lymphoma cell lysis and OVV replication were enhanced both in vitro and in an in vivo murine model system. Conclusion: Our findings indicate the utility of embelin as an adjuvant for oncolytic viro-immunotherapy.Keywords
This publication has 33 references indexed in Scilit:
- Embelin inhibits growth and induces apoptosis through the suppression of Akt/mTOR/S6K1 signaling cascadesThe Prostate, 2012
- XIAP Inhibition and Generation of Reactive Oxygen Species Enhances TRAIL Sensitivity in Inflammatory Breast Cancer CellsMolecular Cancer Therapeutics, 2012
- Embelin suppresses STAT3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase PTENCancer Letters, 2011
- Embelin Suppresses Osteoclastogenesis Induced by Receptor Activator of NF-κB Ligand and Tumor CellsIn vitrothrough Inhibition of the NF-κB Cell Signaling PathwayMolecular Cancer Research, 2010
- Lister strain vaccinia virus, a potential therapeutic vector targeting hypoxic tumoursGene Therapy, 2009
- STATs in cancer inflammation and immunity: a leading role for STAT3Nature Reviews Cancer, 2009
- The immunologic aspects of poxvirus oncolytic therapyCancer Immunology, Immunotherapy, 2009
- Effect of the XIAP Inhibitor Embelin on TRAIL-Induced Apoptosis of Pancreatic Cancer CellsJournal of Surgical Research, 2007
- The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation programVaccine, 2005
- Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species soecificityCell, 1995